Question 1

What is Actemra?

Accepted Answer

Actemra is a biologic medication that contains the active ingredient tocilizumab. It belongs to a class of drugs known as interleukin-6 (IL-6) receptor antagonists.

This medication works by blocking specific proteins in the immune system that trigger inflammation. By interfering with these signals, it helps to manage the body's inflammatory response.

Question 2

What is Actemra used for?

Accepted Answer

Actemra is used to treat:

Rheumatoid arthritis

Juvenile idiopathic arthritis

Giant cell arteritis

and others.

Question 3

How does Actemra work?

Accepted Answer

Mechanism of Action

Actemra belongs to a class of medications known as interleukin-6 (IL-6) receptor antagonists. In a healthy body, IL-6 is a protein that helps regulate the immune system and the inflammatory response. However, in people with certain autoimmune diseases, the body produces too much of this protein.

When there is an excess of IL-6, it attaches to receptors on the surface of cells, sending signals that cause inflammation, pain, and swelling. Actemra works by:

Binding to receptors: The medication attaches itself to both soluble and membrane-bound IL-6 receptors.

Blocking signals: By occupying these receptors, Actemra prevents the IL-6 protein from connecting with the cells.

Reducing inflammation: Because the inflammatory signal is blocked, the body's immune response is dampened, which helps to decrease joint damage and other symptoms.

By interfering with this specific part of the immune system, the medication helps manage the underlying cause of inflammation rather than just treating the pain.

Question 4

What are the active ingredients in Actemra?

Accepted Answer

The active ingredient in Actemra is tocilizumab .

Question 5

What are the side effects of Actemra?

Accepted Answer

Common side effects of Actemra may include:

upper respiratory tract infection

headache

high blood pressure

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Actemra?

Accepted Answer

Actemra belongs to the interleukin-6 receptor antagonist drug class.

Question 7

What is the dosage of Actemra and how do I take it?

Accepted Answer

Administration Methods

Actemra is available in two forms: an intravenous (IV) infusion and a subcutaneous injection. The method used depends on the condition being treated and the recommendation of a healthcare provider.

Intravenous Infusion

The infusion is performed by a healthcare professional in a clinical setting. The medication is delivered directly into a vein, usually over a period of about one hour.

Subcutaneous Injection

The injection is given under the skin, typically in the abdomen, thigh, or outer upper arm. After receiving proper training from a healthcare provider, patients or caregivers may be able to administer these injections at home using a prefilled syringe or autoinjector.

Before injecting, the medication should be removed from the refrigerator and allowed to reach room temperature for the time specified in the product instructions.

Do not shake the syringe or autoinjector.

Rotate injection sites with each dose and avoid injecting into skin that is sore, bruised, red, or hard.

Missed Doses

If a dose is missed, it is important to contact a healthcare provider or pharmacist for guidance on when to schedule the next dose. Do not use extra medicine to make up for a missed dose.

Question 8

Is Actemra safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the safety of Actemra use during pregnancy. It is currently unknown if the medication will cause harm to an unborn baby. Healthcare providers generally recommend that Actemra be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

If you are pregnant or planning to become pregnant, you should discuss your treatment options with your doctor. There is a pregnancy exposure registry that monitors the health of individuals who use Actemra while pregnant and the health outcomes of their infants.

Breastfeeding

It is not known whether Actemra passes into human breast milk or if it could affect a nursing child. Because many medications can be excreted in breast milk and may cause serious side effects in an infant, a decision must be made whether to discontinue breastfeeding or discontinue the drug. This decision should be made in consultation with a healthcare provider, considering the importance of the medication to the mother's health.

Question 9

What forms and strengths does Actemra come in?

Accepted Answer

Actemra is provided in two primary administration formats depending on the condition being treated and the patient's needs:

Intravenous (IV) Infusion: This form is a concentrated solution supplied in single-dose vials. It is administered by a healthcare professional into a vein, typically in a clinical setting.

Subcutaneous (SC) Injection: This form is injected into the fatty tissue just under the skin. It is available in two delivery methods:

A single-dose prefilled syringe.

A single-dose prefilled autoinjector.

The subcutaneous injection may be administered at home by a patient or caregiver after receiving proper training from a healthcare provider. The intravenous form must be administered by a medical professional.

Actemra is supplied in single-use containers. The specific dose and frequency of administration are determined by a healthcare provider based on the patient's body weight and the specific condition being treated.

Question 10

What is the FDA approval status of Actemra?

Accepted Answer

FDA Approval History

Actemra (tocilizumab) was first approved by the U.S. Food and Drug Administration (FDA) in January 2010. It belongs to a class of drugs known as interleukin-6 (IL-6) receptor antagonists. In September 2023, the FDA approved the first biosimilar version of Actemra for the treatment of adult and pediatric arthritis.

Approved Indications

The FDA has approved Actemra for the treatment of several conditions, including:

Rheumatoid arthritis in adults

Giant cell arteritis

Systemic sclerosis-associated interstitial lung disease

Polyarticular juvenile idiopathic arthritis

Systemic juvenile idiopathic arthritis

Cytokine release syndrome caused by CAR T-cell therapy

Hospitalized adults with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation

Boxed Warning

Serious Infections: Actemra contains a boxed warning because it can lower the immune system's ability to fight infections. Some people have developed serious infections while taking this medication, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. These infections may lead to hospitalization or death.

Safety Monitoring

The FDA monitors the safety of Actemra through the FDA Adverse Event Reporting System (FAERS). In 2018, the FDA identified a potential signal of serious risk regarding hepatotoxicity (liver injury), which resulted in updates to the drug's safety information and ongoing monitoring of liver health in patients using the medication.

Question 11

What should I know about Actemra and cost?

Accepted Answer

Factors Affecting Cost

As a biologic medication, Actemra is typically more expensive than non-biologic drugs. The total cost is influenced by several factors:

Administration Method: Actemra is available as an intravenous (IV) infusion or a subcutaneous injection. Infusions administered in a clinical setting may involve additional costs for the facility and healthcare provider services.

Dosage and Frequency: The amount of medication prescribed is often based on the patient's weight and the specific condition being treated, which directly impacts the price per dose.

Insurance and Pharmacy Benefits: Coverage varies widely between private insurance plans, Medicare, and Medicaid. Many plans require prior authorization or may place the drug on a specialty tier with higher copayments.

Biosimilar Availability

The FDA has approved biosimilar versions of Actemra. Biosimilars are medications that are highly similar to the original biologic in terms of safety and effectiveness but are often available at a lower cost. The availability of these alternatives may provide more affordable options for patients and healthcare systems.

Financial Assistance Programs

Because of the high cost of biologic therapy, financial assistance may be available. This can include manufacturer-sponsored copay cards for patients with commercial insurance or patient assistance programs for those who are uninsured or underinsured. Eligibility for these programs is typically based on income and insurance status.

Actemra

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?